Table 2.

Moderate adverse events occurring during immunoadsorption that were classified as being related to vascular access, the immunoadsorption procedure or immunosuppression

	Patients (n = 11)	Immunoadsorption therapies (n = 55)
Vascular access-related
Central venous catheter exit site infection	1 (9.1%)	1 (1.8%)
Jugular vein thrombosis	1 (9.1%)	1 (1.8%)
Side effects during immunoadsorption therapy
Chest pain	1 (9.1%)	1 (1.8%)
Dyspnoe	1 (9.1%)	1 (1.8%)
Transient hypotension	4 (36.5%)	5 (9.1%)
Urticaria	1 (9.1%)	1 (1.8%)
Putatively related to immunosuppression both by steroids and immunoadsorption
Febrile infection	2 (18.2%)	2 (3.6%)